Literature DB >> 1467388

Good sleep, bad sleep: a meta-analysis of polysomnographic measures in insomnia, depression, and narcolepsy.

J I Hudson1, H G Pope, L E Sullivan, C M Waternaux, P E Keck, R J Broughton.   

Abstract

Primary insomnia, major depression, and narcolepsy are usually considered to be separate disorders, distinguished by different polysomnographic profiles. But do polysomnographic data provide adequate evidence to segregate the three disorders, or might they display fundamentally the same sleep disturbance, differing only in degree? To test the viability of these two alternate hypotheses, the authors performed a meta-analysis of controlled polysomnographic studies of these disorders. A summary measure of degree of sleep disturbance was constructed from five variables: wakefulness after sleep onset, percentage of stage 1 sleep, percentage of stage 3 + 4 sleep, rapid eye movement (REM) latency, and REM density. The results of available studies for each variable were combined using a weighted average of effect sizes. An overall "sleep disturbance index" was then calculated by combining the estimates for the five above listed variables. On both the individual measures and especially on the summary index, insomnia, depression, and narcolepsy were arrayed on a simple continuum of progressively more severe sleep disturbance--congruent with the clinical observation that these disorders display progressively more disturbed sleep. These findings suggest that sleep can be disturbed in only a limited number of ways: in evaluating sleep architecture, it may not be possible to elaborate much beyond a single axis of good-to-bad sleep. Thus, polysomnographic measures may not provide adequate evidence to classify insomnia, depression, and narcolepsy as separate entities.

Entities:  

Mesh:

Year:  1992        PMID: 1467388     DOI: 10.1016/0006-3223(92)90058-8

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  7 in total

1.  Sleep-stage transitions during polysomnographic recordings as diagnostic features of type 1 narcolepsy.

Authors:  Julie Anja Engelhard Christensen; Oscar Carrillo; Eileen B Leary; Paul E Peppard; Terry Young; Helge Bjarrup Dissing Sorensen; Poul Jennum; Emmanuel Mignot
Journal:  Sleep Med       Date:  2015-07-07       Impact factor: 3.492

2.  Review of sleep studies of patients with chronic insomnia at a sleep disorder unit.

Authors:  Sheau-Hwa Wong; Beng-Yeong Ng
Journal:  Singapore Med J       Date:  2015-06       Impact factor: 1.858

3.  Preliminary evidence that vortioxetine may improve sleep quality in depressed patients with insomnia: a retrospective questionnaire analysis.

Authors:  C Liguori; L Ferini-Strambi; F Izzi; L Mari; N Manfredi; A D'Elia; N B Mercuri; F Placidi
Journal:  Br J Clin Pharmacol       Date:  2018-10-24       Impact factor: 4.335

4.  Sleep quality deteriorates over a binge--abstinence cycle in chronic smoked cocaine users.

Authors:  Edward F Pace-Schott; Robert Stickgold; Amir Muzur; Pia E Wigren; Amie S Ward; Carl L Hart; Denise Clarke; Alexandra Morgan; J Allan Hobson
Journal:  Psychopharmacology (Berl)       Date:  2005-01-26       Impact factor: 4.530

5.  Rapid eye movements during sleep in mice: high trait-like stability qualifies rapid eye movement density for characterization of phenotypic variation in sleep patterns of rodents.

Authors:  Stephany Fulda; Christoph P N Romanowski; Andreas Becker; Thomas C Wetter; Mayumi Kimura; Thomas Fenzel
Journal:  BMC Neurosci       Date:  2011-11-02       Impact factor: 3.288

6.  Similar polysomnographic pattern in primary insomnia and major depression with objective insomnia: a sign of common pathophysiology?

Authors:  Matthieu Hein; Jean-Pol Lanquart; Gwénolé Loas; Philippe Hubain; Paul Linkowski
Journal:  BMC Psychiatry       Date:  2017-07-28       Impact factor: 3.630

7.  Cognitive behavioural therapy for insomnia reduces sleep apnoea severity: a randomised controlled trial.

Authors:  Alexander Sweetman; Leon Lack; R Doug McEvoy; Nick A Antic; Simon Smith; Ching Li Chai-Coetzer; James Douglas; Amanda O'Grady; Nicola Dunn; Jan Robinson; Denzil Paul; Danny Eckert; Peter G Catcheside
Journal:  ERJ Open Res       Date:  2020-05-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.